Genetical and engineering biological therapy of psoriasis. Martsov A.V., Kheitdinov V.R.

The rate of replenishment of medical knowledge over the past decade dictates the need for publications of new generation, which is systematic by the statement of reference materials, conciseness, and reliability of information. This leadership is the only modern source of information about all classes of genetically engineering biological drugs used in the treatment of patients with psoriasis. The book is extremely necessary for a practitioner dermatovenerologist, and the data given in it allow you to determine the patient’s profile taking into account clinical symptoms, the presence of psoriatic arthritis and comorbid pathology.

The guide is optimally structured and includes all the relevant information on the use biological therapy for psoriasis in accordance with the classes of drugs. Efficiency and safety issues are highlighted, including in a comparative aspect. Particular attention is paid to safety monitoring during taking genetically engineering biological drugs, as well as their use in various clinical forms and in childhood patients. Combined methods are separately considered and, very importantly, data on the use of biological therapy in conditions of covid infection.

The book will help practicing doctors in determining the drug of choice in case of loss of therapy, as well as in other difficult clinical situations. Designed for dermatologists, rheumatologists, immunologists of allergists, pediatricians.